Sterling Pharmaceuticals recalls KidNaps Melatonin due to stability issues
Sterling Pharmaceuticals Ltd and Veriton Pharma Ltd are recalling all batches of KidNaps (Melatonin) 1mg in 1ml Oral Solution due to out of specification stability results.
Company
Sterling Pharmaceuticals Ltd
Signal assessment
Signal strength
high
Confidence level
high
Why it matters
The recall of KidNaps due to stability issues poses significant risks to market confidence in melatonin products, which could lead to a shift in consumer preference towards competitors. Pharma strategy teams must evaluate the potential impact on market share and regulatory compliance as they navigate this situation.
Recommended action
Humanexa recommends Investigate.
Analysis
Monitor for updates on the recall process and any regulatory actions taken by health authorities.
Related companies & assets
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.